361Single-cell multi-omic and spatial profiling of esophageal squamous cell carcinoma reveals the immunosuppressive role of GPR116<sup>+</sup> pericytes in cancer metastasis.2025 · Europe PMC
363Detection of Human Papillomavirus (HPV) in HPV-Associated Oropharyngeal Squamous Cell Carcinoma: A Review of Diagnostic Approach and Its Importance for the Head and Neck Oncologist.2025 · Europe PMC
364Prognostic role of tumour volume and downstaging response on outcome after liver transplantation for colorectal liver metastases: retrospective study.2025 · Europe PMC
366The prediction value of LOXL-2 in the clinical pathology and prognosis of cancers: A meta-analysis and bioinformatics analysis.2025 · Europe PMC
368Correlation of EZH2 expression and response to chemoradiation in patients with locally advanced inoperable oral cavity and oropharyngeal squamous cell cancers.2025 · Europe PMC
369Synchronous Versus Metachronous Multiple Malignant Tumors Involving the Digestive Tract: Predictors of Survival from a Single-Center Retrospective Study.2025 · Europe PMC
370Albumin-globulin ratio is a predictive biomarker of antitumour effect of immune checkpoint inhibitors in cancer patients.2025 · Europe PMC
371Pathology reporting of hepatoblastoma resections: recommendations from the international collaboration on cancer reporting.2025 · Europe PMC
372Intraductal papillary neoplasm of the biliary tract with typical clinicopathological, endoscopic features: A case report.2025 · Europe PMC
373Double Pathogenic or Likely Pathogenic Variants in Cancer Predisposition Genes in Hungarian Cancer Patients.2025 · Europe PMC
374Correlation of Galectin Family Expression with Glioblastoma Progression and Survival.2025 · Europe PMC
375Pediatric Oncology Patients With Germline Pathogenic Variants in Adult-Onset Cancer Predisposition Genes.2025 · Europe PMC
376High expression of CDKN2A in oral squamous cell carcinoma is associated with distant metastasis: Cell-free DNA as a new prognostic feature.2025 · Europe PMC
377Cadherin 1 germline mutation co-occurs with medullary thyroid cancer and choroid plexus papilloma: A case report and review of literature.2025 · Europe PMC
378Innovations in cancer treatment as novel potential and the myth of personalized vaccines, immunotherapy, CRISPR/Cas9, and bacteriotherapy as promising therapeutic strategies.2025 · Europe PMC
379Failure pattern and salvage in head and neck cancer of unknown primary: A national study by DAHANCA.2025 · Europe PMC
380A Challenging Decision: Identifying and Managing Hepatic Hydrothorax in the Setting of a Pancreatic Neuroendocrine Tumor.2025 · Europe PMC
381Spontaneous regression of metastatic disease after palliative debulking surgery for heavily pre-treated extraskeletal myxoid chondrosarcoma: A case report.2025 · Europe PMC
382Risk stratification for metachronous metastasis in colon cancer based on landscape ecological analysis.2025 · Europe PMC
383Inhibiting SLAMF8 modulates tumor-associated macrophages and restores CD8+ T cell-mediated antitumor immunity in colorectal cancer.2025 · Europe PMC
384Neo-Rib Technique of Chest Wall Reconstruction Following Oncological Resection: An Institutional Experience.2025 · Europe PMC
385Synthetic Flozins in Cancer Prevention and Combination Strategies: Structural Insights and Therapeutic Potential.2025 · Europe PMC
386Primary Breast Implant-Associated Squamous Cell Carcinoma: A Proposal for a Better Surgical Approach and Clinical Staging System Based on Tumour Characteristics.2025 · Europe PMC
387Case report: Curative effect and mechanism of surufatinib combined with toripalimab in the treatment of 1 case of lung large-cell neuroendocrine carcinoma.2025 · Europe PMC
388Extracellular vesicle-induced lipid dysregulation drives liver premetastatic niche formation in colorectal cancer.2025 · Europe PMC
389Impact of Multidisciplinary Team Care on Patient-Reported Outcomes in Patients with Lung Cancer: A Systematic Review.2025 · Europe PMC
391Advances in colorectal cancer screening: technological innovations, guideline discrepancies, and individualized strategies.2025 · Europe PMC
392Association between insulin resistance biomarkers and metastatic prognosis in treatment-naïve colorectal cancer patients: a pilot study.2025 · Europe PMC
393Ivonescimab plus chemotherapy versus tislelizumab plus chemotherapy as first-line treatment for advanced squamous non-small-cell lung cancer (HARMONi-6): a randomised, double-blind, phase 3 trial.2025 · Europe PMC
394[Antibody-drug conjugates in breast cancer: Resistance mechanisms and prospects].2025 · Europe PMC
395Commentary on "molecular features of T and N stage progression in laryngeal cancer".2025 · Europe PMC
396Executive Summary of the American Radium Society Appropriate Use Criteria for Management of Early Glottic Cancer: A Review.2025 · Europe PMC
397Suicide Ideation, Attempt and Mortality in Childhood Cancer Survivors a Scoping Review of the Literature.2025 · Europe PMC
398p16 expression and its correlation with the clinical pathological characteristics of patients with cervical cancer: a systematic review and meta-analysis.2025 · Europe PMC
399A novel risk score after neoadjuvant imatinib predicts relapse-free survival in patients with gastrointestinal stromal tumours (GIST).2025 · Europe PMC
400Role of fallopian tube and cervical canal occlusion in preventing intra-operative tumour spillage in early endometrial cancer- a pilot study.2025 · Europe PMC
401Mapping the global research landscape of perineural invasion in gastrointestinal malignancies: a bibliometric visualization analysis.2025 · Europe PMC
402A case report: Achieving complete response in synchronous primary lung and tongue squamous cell carcinomas through the integration of albumin-bound paclitaxel, cisplatin, and tislelizumab.2025 · Europe PMC
403Multiple primary cancers with prostate malignant tumor as the initial diagnosis: a case report.2025 · Europe PMC
404Implementing perioperative immunotherapy for head and neck cancer after KEYNOTE-689: questions and challenges.2025 · Europe PMC
405Recent advances in tumour microenvironment impact immunotherapy resistance in gastric cancer.2025 · Europe PMC
406Postoperative CA-125 as a Prognostic Marker for Overall Survival in Ovarian Cancer.2025 · Europe PMC
407Diffuse infiltrating retinoblastoma: a multicentre, international, data-sharing study.2025 · Europe PMC
408Neutrophil-albumin ratio and multi-phase computed tomography for lymph node metastasis in pancreatic cancer.2025 · Europe PMC
409A retrospective and comparative analysis of survival in testicular non-germ cell tumors.2025 · Europe PMC
410Emergency embolisation of acute adrenal gland haemorrhages due to underlying neoplasms - multicentre experience and literature overview.2025 · Europe PMC
411Circulating tumour cells and circulating tumour DNA in head and neck cancer: from molecular insights to clinical impact.2025 · Europe PMC
412The application of artificial intelligence in veterinary oncology: a scoping review.2025 · Europe PMC
413Baseline tumour burden and prognosis in breast cancer treated with immune checkpoint inhibitors.2025 · Europe PMC
414Postoperative Circulating Tumour DNA in Predicting Recurrence of Non-small Cell Lung Cancer: A Systematic Review and Meta-analysis.2025 · Europe PMC
415Patient-derived organoids for the personalized treatment of pancreatic neuroendocrine tumor with liver metastases: A case report.2025 · Europe PMC
416TRENDS OF HOSPITAL-BASED REPORTING OF INTRACRANIAL NEOPLASMS IN NIGERIA FROM 1960 - 2024: A SYSTEMATIC REVIEW AND POOLED ANALYSIS OF LITERATURES2025 · Europe PMC
417Circulating tumour DNA in patients with stage III colon cancer: multicentre prospective PROVENC3 study.2025 · Europe PMC
418Grade 3 and grade 4 cutaneous toxicities in patients with multiple solid tumour types receiving checkpoint inhibitor therapy: an observational study. The experience of a single large specialist institution.2025 · Europe PMC
419Cancer of unknown primary site and TNM staging: a new paradigm for patient management.2025 · Europe PMC
420Oral cancer in women: clinical profile, risk factors, treatment outcomes and survival predictors in 32 years of experience.2025 · Europe PMC